Aloxi (palonosetron HCl injection) 0.075mg has been made available by Eisai and Helsinn for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery.

The Aloxi injection 0.25mg dosage strength is already available on the market for the prevention of acute and delayed nausea and vomiting due to initial and repeat courses of moderately emetogenic chemotherapy, and for the prevention of acute nausea and vomiting due to initial and repeat courses of highly emetogenic chemotherapy.

For more information call (800) 562-5580 or visit www.aloxi.com.